SAVYSCUS
LIVE

Serial Number

98210960

Owner

FUJIFILM CORPORATION

Attorney

Suzanne M. Hengl

Filing Date

Oct 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SAVYSCUS Trademark

Serial Number: 98210960 • Registration: 7782286

SAVYSCUS is a trademark filed by FUJIFILM CORPORATION on October 5, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

FUJIFILM CORPORATION (524 trademarks)

26-30, NISHIAZABU 2-CHOME, MINATO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

October 5, 2023

Registration Date

May 6, 2025

Published for Opposition

March 11, 2025

Goods & Services

Custom processing of human cells, for others; custom manufacturing, namely, compounding and processing of chemicals, for others; consultancy relating to custom manufacturing in the nature of formulating and processing of chemicals; custom manufacturing, namely, producing and processing of chemicals and proteins, for others; consultancy relating to custom manufacturing in the nature of producing and processing of chemicals and proteins; providing technical information in the field of chemical manufacturing; custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of dietary supplements; rental of chemical processing machines; processing of medical materials, namely, custom fabrication and assembly of artificial materials for use in the replacement of bones, cartilage, skin, tissue and muscles

Pharmaceutical preparations for the treatment of musculo-skeletal disorders, damaged skin and tissue, and for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for treating and preventing knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; reagent paper for medical purposes; cultured cells intended for subsequent injection and/or implantation in the treatment of cartilage and meniscus injuries; stem cells for medical and veterinary purposes; medical diagnostic pharmaceutical preparations for use in diagnosis of musculo-skeletal, tendon cartilage, and meniscus disorders and injuries; implants comprising living tissue; reagent kits for medical purposes comprising chemical agents, skin, cartilage and other cells; cell growth media for growing cells for medical use; cellular function activating agents for medical purposes; cells for medical use; stem cell preparations for the treatment of muscular dystrophy, musculoskeletal disorders, damaged skin and tissue, and for treating tendon and muscle injuries and disorders, sports related injuries, and for treating knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; medicinal preparations for musculo-skeletal disorders, damaged skin and tissue, and for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for treating and preventing knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; medical diagnostic reagents; biochemical preparations for medical purposes, namely, for the diagnosis and treatment of musculo-skeletal disorders, damaged skin and tissue, and for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for treating and preventing knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; biological tissue cultures for medical purposes, namely, for medical gene cell therapy; biological tissue cultures for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; medical adhesives for binding internal tissue and for binding wounds; culture media for use in augmentation of bone and tissue for medical purposes

Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; consulting services in the field of medical care; medical diagnostic and therapy services using regenerative medicine; medical therapy services using cultured cells; stem cell therapy services; medical diagnostic and therapy services using genetic information; health counseling; rental of medical equipment; dietary and nutritional guidance; veterinary services; medical services relating to the processing of human cells for the treatment of muscular dystrophy, musculo-skeletal disorders, damaged skin and tissue, and for treating tendon and muscle injuries and disorders, sports related injuries, and for treating knee cartilage and meniscus injuries and disorders, and for knee cartilage and meniscus regeneration; consultancy in the field of transplantation of cultured skin

Medical apparatus and instruments for use in orthopedic surgery and stem cell transplants; apparatus for the regeneration of stem cells for medical purposes; auxiliary medical devices in the nature of orthopedic support apparatus, and orthodontic apparatus comprising headgear, brackets and appliances; cell culture apparatus for medical use, namely, cell culture chambers; surgical apparatus and instruments for veterinary use; osseous implants made of artificial materials; medical implants made of artificial materials

Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; research and development services in the field of cytology; medical and scientific research services, namely, custom cell culturing; testing, inspection, research and development of cell and tissue culturing; research and development of medicines; testing the functionality of machines; research on machines; testing the functionality of medical machines; research on medical machines; providing temporary use of on-line nondownloadable computer programs for use in database management and for analysis of medical diagnostic information; cloud computing featuring software for use in storing, analysis and sharing of medical diagnostic information; cloud computing featuring software for use in database management, information management, data collection and data analysis in the medical field; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; research and development services in the field of medical preparations; scientific research and development in the field of product development of pharmaceutical preparations and test reagents, and consultancy services relating thereto; scientific research and development; medical research; scientific investigations for medical purposes; computer programming; computer programming and software design; technical advice relating to the operation of computers, automobiles and industrial machines; rental of measuring apparatus; rental of laboratory apparatus and instruments; rental of computers; custom design and development of chemical reagents

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 10, 2025 ERRR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 16, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 10, 2024 CNRT
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 26, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 26, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 26, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2024 CRFA
ASSIGNED TO LIE
Sep 30, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 17, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2023 NWOS
NEW APPLICATION ENTERED
Oct 9, 2023 NWAP